A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 13, 2019

Primary Completion Date

December 6, 2019

Study Completion Date

December 6, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

TAK-123

TAK-123 infusion

Trial Locations (1)

Sekino Clinical Pharmacology Clinic, Toshima-ku